Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ce |
RCV000997474 | SCV001152921 | uncertain significance | not provided | 2023-07-01 | criteria provided, single submitter | clinical testing | TTN: PM2, BP4 |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV003482157 | SCV003934179 | uncertain significance | not specified | 2023-05-23 | criteria provided, single submitter | clinical testing | Variant summary: TTN c.35774A>G (p.Glu11925Gly) results in a non-conservative amino acid change located in the I-band region of the encoded protein sequence. Two of four in-silico tools predict a benign effect of the variant on protein function. 4/4 computational tools predict no significant impact on normal splicing. However, these predictions have yet to be confirmed by functional studies. The variant allele was found at a frequency of 4e-06 in 247096 control chromosomes (gnomAD). The available data on variant occurrences in the general population are insufficient to allow any conclusion about variant significance. To our knowledge, no occurrence of c.35774A>G in individuals affected with Dilated Cardiomyopathy and no experimental evidence demonstrating its impact on protein function have been reported. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014. Based on the evidence outlined above, the variant was classified as uncertain significance. |